Back to search
FDAFDA · Food and drugs·Recall number Z-2296-2013

MedStream Refill Kit (1 unit), EMEA: 91-4289 Product Usage: The Medstream programmable pump is intended for the intrathecal delivery of Baclofen in the US market and for the intrathecal delivery of Morphine or Baclofen in the EMEA market. Refill Kits- are intended for use in the filling and re-filling of the Medstream pump reservoir.

Published October 9, 2013 · Recall initiated: August 13, 2013

Summary

FDA records medical device Class I recall Z-2296-2013, published October 9, 2013 and initiated August 13, 2013. Recalling firm: Codman & Shurtleff, Inc.; Status: Terminated; Reported quantity: OUS: 2168 units; Lot: OUS: Per recall strategy. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Drug flow rates exceeding programmed flow rates.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Codman & Shurtleff, Inc.
Distributor
Worldwide Distribution - USA Nationwide in the states of NJ, NC, TX, FL and in the countries of Austria, Belgium, Egypt, Germany, Greece, Ireland, Israel, Italy, Luxemborg, Portugal, Russia, Saudi Arabia, Slovenia, Spain, Sweden, Switzerland, Turkey, and UK.
Lot
OUS: Per recall strategy
Risk classification
Class I
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was MedStream Refill Kit (1 unit), EMEA: 91-4289 Product Usage: The Medstream programmable pump is intended for the intrathecal delivery of Baclofen in the US market and for the intrathecal delivery of Morphine or Baclofen in the EMEA market. Refill Kits- are intended for use in the filling and re-filling of the Medstream pump reservoir. recalled?

Yes. FDA published recall Z-2296-2013 on October 9, 2013. Reported hazard: Drug flow rates exceeding programmed flow rates.

What should I do if I have this product?

Voluntary: Firm initiated · Letter